BioRestorative Therapies CEO Lance Alstodt's 2022 pay falls 98% to $452K
BioRestorative Therapies reports 2022 executive compensation
By ExecPay News
Published: August 4, 2023
BioRestorative Therapies reported fiscal year 2022 executive compensation information on August 4, 2023.
In 2022, three executives at BioRestorative Therapies received on average a compensation package of $352K, a 98% decrease compared to previous year.
Average pay of disclosed executives at BioRestorative Therapies
Lance Alstodt, Chief Executive Officer, received $452K in total, which decreased by 98% compared to 2021. 88% of Alstodt's compensation, or $400K, was in salary. Alstodt also received $52K in stock awards.
Francisco Silva, VP, Research and Development, received a compensation package of $427K, which decreased by 98% compared to previous year. 88% of the compensation package, or $375K, was in salary.
Robert Kristal, Chief Financial Officer, earned $175K in 2022, a 112% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on August 4, 2023.